clinical evidence

    Clinical Deployment Perspectives from the VA

    Notes from the field on what it actually takes to deploy a bioelectric pain program inside a large veteran serving health system.

    AC
    ActiPatch® Clinical Affairs
    Editorial
    December 10, 2025 3 min read
    Clinical Deployment Perspectives from the VA

    Clinical deployment inside a large veteran serving system is not a software install. It is a coordinated change to a clinical workflow, and the parts that matter most are usually the parts that are not visible from the outside. This piece collects the lessons that have been most consistent across deployments of bioelectric pain programs in VA aligned settings.

    Start with the workflow, not the device

    The first lesson is that the device is the easy part. The workflow is the work. A successful deployment starts by mapping how patients with chronic musculoskeletal pain currently move through the system, where the bioelectric option fits, and what changes for the clinical team. The mapping is short. A few hours with the right people. Skipping it is the most common avoidable mistake.

    Identify the right initial cohort

    The second lesson is that the initial cohort matters. The right cohort is patients with a clear musculoskeletal pain indication that aligns with the FDA cleared use of pulsed shortwave therapy, who have the digital comfort to work with a wearable, and whose clinical team is willing to integrate the data. That cohort is large enough to be meaningful and small enough to be operationally tractable. Trying to deploy across an undifferentiated patient panel makes the early data noisy and the early operations unstable.

    Set the patient expectation cleanly

    The third lesson is the patient conversation. A bioelectric wearable is not a miracle device. It is a tool that, used consistently for an adequate duration each day, contributes to a multimodal pain management plan. Setting that expectation up front is what produces durable adherence. Patients who are told to expect a transformation in week one and do not see one will stop using the device. Patients who are told to expect a steady accumulation of benefit over weeks will use it.

    Make the documentation a byproduct

    The fourth lesson is documentation. The platform should produce the documentation that the system needs as a byproduct of normal usage, not as a separate task. RTM compliant records, adherence summaries, outcomes notes. The clinician should be reviewing the platform's output, not generating it. When the documentation requires manual work, the program loses momentum.

    Close the loop with the broader care team

    The fifth lesson is the loop. A bioelectric program inside a VA setting is one part of a multimodal care plan. The data has to be available to physical therapy, to primary care, and to the patient's mental health support when relevant. A platform that surfaces the data only inside its own workspace is a platform that is partially deployed. Real deployment closes the loop with the broader care team.

    Operational expectations

    Operationally, a deployment of this kind takes weeks, not months, when the workflow mapping has been done well. Clinical training is short, because the device is simple and the platform is built around the existing workflow. The first month produces noisy data. The second month produces a baseline. The third month produces a signal. The cohort that survives that arc tends to stay engaged and tends to drive the program's expansion organically.

    Citations

    1. 1.Galace de Freitas D, et al.. Pulsed shortwave therapy in chronic musculoskeletal pain, multi center deployment. PMC (2024) Source
    AC
    ActiPatch® Clinical Affairs
    Editorial, Electrome